Schrodinger (NASDAQ:SDGR) Trading 10.4% Higher - What's Next?

Key Points

• Schrödinger shares jumped 10.4% to $19.52 in Wednesday trading, reaching an intraday high of $19.63, while volume remained below the stock’s average.
• Analysts remain broadly cautious, with a consensus “Hold” rating and a $20.50 target price. Recent updates included UBS initiating coverage at Neutral with a $19 target and Morgan Stanley lowering its target to $17.
• The company exceeded quarterly expectations, reporting $0.08 EPS versus the projected $0.41 loss and $58.89 million in revenue, up 7.5% year over year. Despite the beat, Schrödinger remains unprofitable, with analysts forecasting a full-year loss of $1.89 per share.

Schrodinger, Inc. (NASDAQ:SDGR - Get Free Report)'s stock price rose 10.4% during trading on Wednesday . The company traded as high as $19.63 and last traded at $19.5150. 1,100,468 shares traded hands during mid-day trading, a decline of 18% from the average daily volume of 1,339,451 shares. The stock had previously closed at $17.67.

Analyst Upgrades and Downgrades

SDGR has been the subject of a number of research analyst reports. Weiss Ratings cut Schrodinger from a "sell (d-)" rating to a "sell (e+)" rating in a report on Wednesday, August 12th. Morgan Stanley decreased their target price on shares of Schrodinger from $19.00 to $17.00 and set an "equal weight" rating on the stock in a research report on Thursday, May 14th. Wall Street Zen upgraded shares of Schrodinger from a "strong sell" rating to a "hold" rating in a research report on Saturday, August 8th. Finally, UBS Group initiated coverage on shares of Schrodinger in a research note on Friday, August 14th. They issued a "neutral" rating and a $19.00 price target on the stock. Three investment analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $20.50.

Schrodinger Trading Up 10.0%

The stock has a market cap of $1.44 billion, a PE ratio of -26.32 and a beta of 1.63. The company has a fifty day moving average of $16.13 and a 200-day moving average of $13.82.

Schrodinger (NASDAQ:SDGR - Get Free Report) last announced its earnings results on Wednesday, August 5th. The company reported $0.08 EPS for the quarter, beating analysts' consensus estimates of ($0.41) by $0.49. The company had revenue of $58.89 million during the quarter, compared to analysts' expectations of $47.19 million. Schrodinger had a negative return on equity of 16.37% and a negative net margin of 20.98%.Schrodinger's revenue for the quarter was up 7.5% on a year-over-year basis. During the same period last year, the business posted ($0.65) EPS. As a group, research analysts anticipate that Schrodinger, Inc. will post -1.89 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the business. EverSource Wealth Advisors LLC boosted its position in Schrodinger by 722.8% in the 4th quarter. EverSource Wealth Advisors LLC now owns 1,374 shares of the company's stock valued at $25,000 after buying an additional 1,207 shares during the period. Los Angeles Capital Management LLC acquired a new stake in shares of Schrodinger in the fourth quarter valued at $26,000. Hantz Financial Services Inc. raised its stake in shares of Schrodinger by 5,025.8% in the fourth quarter. Hantz Financial Services Inc. now owns 1,589 shares of the company's stock valued at $28,000 after acquiring an additional 1,558 shares in the last quarter. Fideuram Intesa Sanpaolo Private Banking S.P.A. purchased a new position in Schrodinger in the fourth quarter valued at $36,000. Finally, State of Wyoming purchased a new position in Schrodinger in the second quarter valued at $39,000. Institutional investors and hedge funds own 79.05% of the company's stock.

Schrodinger Company Profile

Schrödinger, Inc is a life sciences and materials discovery company that specializes in the application of physics-based computational platforms to accelerate drug discovery and advanced materials design. Founded in 1990 by Professor Richard A. Friesner, Schrödinger has developed a suite of proprietary software tools—such as Maestro for molecular modeling, Glide for molecular docking and Jaguar for quantum chemistry calculations—that enable scientists to predict molecular behavior with high accuracy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source